How Much Is Too Much Baclofen? Signs of Overdose

Baclofen becomes dangerous at surprisingly modest amounts above its prescribed range, with doses of 200 mg or more consistently linked to serious complications like coma, seizures, and respiratory failure. The standard therapeutic ceiling for oral baclofen is 80 mg per day for most adults, though some clinicians prescribe well beyond that for alcohol use disorder. That gap between a therapeutic dose and a potentially lethal one is narrow enough that accidental overdoses, intentional self-poisoning, and even small prescribing errors can land someone in an intensive care unit. The reassuring part is that most people survive a baclofen overdose with supportive care, but the window between “fine” and “life-threatening” depends heavily on factors like kidney function and what other substances are on board.

Where the Therapeutic Dose Ends and Toxicity Begins

For spasticity, the usual oral dose of baclofen tops out around 80 mg per day, split into several doses. Most people start much lower, around 5 mg three times daily, and increase gradually. At these levels, the drug relaxes muscles effectively without pushing the brain into dangerously deep sedation. Problems tend to start at total ingested doses well above the daily therapeutic range. In one study that characterized 19 overdose patients, the mean amount swallowed was 630 mg, with a range from 80 mg to 2,500 mg. Coma, delirium, and seizures appeared exclusively in patients who had taken 200 mg or more, and those patients were far more likely to need ICU admission and mechanical ventilation.¹

A large systematic review found a similar pattern: central nervous system depression showed up in roughly two-thirds of toxicity cases, seizures in about a third, and respiratory depression in about one in five, with doses of 300 mg and above most strongly associated with severe presentations.² That said, there is no single magic number that separates “safe” from “toxic” for everyone. A 200 mg dose that causes seizures in one person might only cause drowsiness in another, depending on tolerance, body weight, kidney function, and whether alcohol or other sedating drugs are involved.

Recognizing the Signs of Overdose

Baclofen overdose tends to announce itself through the nervous system first. Because baclofen amplifies the brain’s main inhibitory signaling, too much of it effectively dials down brain activity far beyond what is helpful. The earliest signs are excessive drowsiness, confusion, and slurred speech. As the dose climbs, the progression can be rapid and frightening.

The hallmark symptoms of a significant overdose include:

Deep sedation or coma: Patients may become unresponsive, sometimes profoundly so. In severe cases, reflexes disappear entirely.
Respiratory depression: Breathing slows or stops, which is the most immediately life-threatening complication. About half of hospitalized overdose patients in the systematic review needed mechanical ventilation.²
Seizures: These can occur even in people with no seizure history and tend to show up at higher doses.³
Cardiovascular instability: Heart rate may drop (bradycardia), blood pressure can swing between dangerously high and low, and cardiac conduction abnormalities have been reported.⁴
Autonomic instability: Hypertension paired with bradycardia is a classic combination in serious baclofen poisoning.⁵

The speed of onset matters too. Oral baclofen is absorbed relatively quickly from the gut, and symptoms can appear within one to two hours of ingestion. If someone has taken a large amount and is already becoming drowsy, the window to intervene before they stop breathing on their own can be narrow.

Why Kidney Function Changes the Equation

Roughly 80 to 85 percent of baclofen is cleared from the body by the kidneys.⁶ That makes kidney function perhaps the single most important variable in determining whether a given dose becomes toxic. A person with healthy kidneys eliminates the drug at a predictable rate. Someone with impaired kidneys, whether from chronic kidney disease, age-related decline, or dehydration, clears it much more slowly, allowing the drug to accumulate to dangerous levels even at prescribed doses.

Most reported cases of baclofen neurotoxicity at therapeutic or near-therapeutic doses have occurred in patients with impaired kidney function, typically developing within days to weeks of starting the drug.⁷ This means a dose that is perfectly safe for one person can cause toxicity in someone whose kidneys are not working well. For older adults especially, whose kidney function often declines without obvious symptoms, baclofen dosing requires careful attention. If you or a family member takes baclofen and has any degree of kidney disease, that information should be front and center in every conversation with a prescriber.

Children and Accidental Ingestion

Young children are particularly vulnerable to baclofen poisoning because their smaller body size means even a few tablets can constitute a massive relative dose. Case reports of accidental pediatric ingestion paint a consistent picture: a toddler or young child finds a family member’s medication, swallows a handful of pills, and rapidly becomes unconscious.

A three-year-old girl who accidentally ingested baclofen presented with coma, bradycardia, and low blood pressure but recovered within 24 hours with supportive treatment.⁸ A five-year-old boy who received a toxic dose developed convulsions, drowsiness, and a slow heart rate, and also recovered within 24 hours once his seizures were controlled.⁹ A more severe case involved a four-year-old who fell into a deep coma, required mechanical ventilation for 36 hours, and showed brain-imaging findings suggestive of diffuse swelling before eventually making a full recovery.¹⁰

The consistent theme across pediatric cases is that children can look terrifyingly sick but still recover fully, provided they get to a hospital in time. The practical takeaway for any household with baclofen is straightforward: treat the medication like any other potentially lethal drug and keep it locked away from children. The number of reports of pediatric baclofen ingestion has been increasing, likely reflecting broader prescribing of the drug for conditions like alcohol use disorder in adults, which puts more bottles in more medicine cabinets.

Intrathecal Baclofen Pumps Carry Their Own Risks

Baclofen is not only taken as a pill. For people with severe, intractable spasticity from spinal cord injuries, cerebral palsy, or multiple sclerosis, baclofen can be delivered directly into the spinal fluid through a surgically implanted pump. This intrathecal route uses doses measured in micrograms, not milligrams, because the drug bypasses the bloodstream and acts directly on the spinal cord. A dose that would be trivial orally can be catastrophic intrathecally.

Overdose from an intrathecal pump can happen when the pump is filled with the wrong concentration of baclofen, when the pump rate is set too high, or when the device itself malfunctions and delivers more medication than programmed.¹¹ There is no specific antidote for intrathecal baclofen overdose. Management involves immediately stopping the pump, sometimes draining spinal fluid to physically remove the drug, and providing intensive supportive care.¹²

In a small number of intrathecal overdose cases, intravenous physostigmine (a drug that boosts the signaling molecule acetylcholine) has reversed respiratory depression and coma caused by intrathecal baclofen boluses ranging from 80 to 800 micrograms. Physostigmine is not a specific baclofen antidote, but it has provided enough reversal to improve outcomes in case reports.¹³ Pump-related overdose and withdrawal are both emergencies, and anyone with an intrathecal baclofen pump should have a clear plan with their medical team for recognizing the signs of each.

When Baclofen Overdose Mimics Brain Death

One of the most alarming features of severe baclofen toxicity is how closely it can resemble irreversible brain damage. In extreme cases, patients have lost all brainstem reflexes, stopped breathing on their own, and appeared clinically brain dead, only to wake up and recover completely once the drug cleared their system. This phenomenon has been documented in multiple case reports and creates a genuine diagnostic trap for emergency physicians.

A case described in BMJ Case Reports documented a patient who entered a state mimicking brain death for six hours before experiencing a complete recovery.¹⁴ Other reports have described prolonged, profound coma with absent brainstem reflexes that fully resolved.¹⁵ The danger here is not just for the patient’s body but for the clinical decision-making around them. If a doctor does not suspect baclofen and focuses instead on post-cardiac-arrest brain injury or stroke, premature decisions about withdrawal of care could be made.¹⁶

The lesson from this literature is unambiguous: baclofen toxicity should always be considered in unexplained coma, especially when a patient has access to the drug. One case report described a patient whose neurological presentation looked indistinguishable from severe oxygen-deprivation brain damage, but who fully recovered within 72 hours once the correct cause was identified.¹⁷

How Baclofen Overdose Is Treated

There is no approved reversal agent for oral baclofen overdose. Treatment is fundamentally supportive: protect the airway, ventilate the lungs if breathing stops, manage seizures with standard anti-seizure medications, and wait for the drug to clear. This approach works well for most patients. The systematic review of toxicity cases found that full clinical recovery occurred in nearly 98 percent of cases, with mortality generally between zero and four percent in large retrospective studies.²

For patients whose kidneys cannot clear the drug efficiently, or when symptoms are severe and prolonged even with normal kidneys, hemodialysis can dramatically speed up elimination. In one documented case, a 55-year-old man who took 420 mg of baclofen was intubated for respiratory depression. His elimination half-life without dialysis was measured at about 16 hours; during hemodialysis, that dropped to about 3 hours. He regained consciousness 9 hours after dialysis ended and was successfully taken off the ventilator.¹⁸ Dialysis is not routinely needed for every baclofen overdose, but it is a useful tool when the clinical picture is not improving on its own or when kidney disease is slowing natural clearance.

Activated charcoal may be considered if the patient presents within about an hour of ingestion and can safely swallow it, but since baclofen is absorbed quickly and many overdose patients arrive already sedated, the window for charcoal is often already closed.

The Complicated Picture With High-Dose Prescribing

In several countries, clinicians have experimented with baclofen doses far above the conventional 80 mg ceiling to treat alcohol use disorder, sometimes reaching 300 mg per day or more. This practice has been most widespread in France, Australia, and Germany, where patient-tailored dose escalation has become a recognized, if controversial, approach.¹⁹ Baclofen acts on the same type of receptor that is involved in addiction-related brain circuits, which is why it has attracted interest for reducing alcohol cravings.²⁰

The safety concern here is not straightforward overdose but rather chronic high-dose exposure interacting with other sedating substances. Patients being treated for alcohol use disorder are, almost by definition, often still drinking or recently drinking, and many also take benzodiazepines or other sedatives. The combination of high-dose baclofen with alcohol or other depressants creates a layered sedation risk that is hard to attribute to any single drug. Frequent side effects at high doses include excessive sedation, dizziness, insomnia, and tinnitus. Rarer but serious adverse effects include seizures, manic episodes, and sleep apnea.¹⁹

The increase in high-dose prescribing has also led to a measurable rise in intentional self-poisoning with baclofen. A review of poison control data from western France covering over 12 million people found 111 cases of intentional baclofen self-poisoning over about six years, with four deaths. Severity was significantly associated with co-existing psychiatric disorders.²¹ When a drug is prescribed in large quantities to a population that already has high rates of psychiatric illness and substance use, the self-harm risk is a real consideration that prescribers have to weigh against the potential benefit for cravings.

Overdose Versus Withdrawal

Baclofen overdose and baclofen withdrawal are both medical emergencies, but they look very different. Overdose pushes the brain into excessive inhibition: deep sedation, depressed breathing, slowed heart rate. Withdrawal does the opposite, producing a rebound of excitation: agitation, delirium, hallucinations, rapid heart rate, sweating, and sometimes seizures. Withdrawal typically develops one to four days after baclofen is abruptly stopped and resolves when the drug is restarted.²

The confusion between these two states matters in practice. Someone on an intrathecal baclofen pump who develops sudden agitation and fever might be experiencing pump failure and withdrawal, not overdose. Conversely, someone found unresponsive next to an empty bottle of pills is likely dealing with overdose, not withdrawal. Getting the direction wrong means delivering the wrong treatment: you would not restart baclofen in an overdose patient, and you would not withhold it from someone in dangerous withdrawal. For people who take baclofen regularly at any dose, the safest course is never to stop abruptly without medical guidance, even if the drug seems to be causing problems.

What Makes Some People More Vulnerable

Beyond kidney disease, several factors lower the threshold at which baclofen becomes toxic. Older adults tend to be more sensitive to central nervous system depressants in general, and age-related decline in kidney function compounds this. People taking other sedating medications, including opioids, benzodiazepines, sleep aids, or certain antidepressants, face a higher risk from any given baclofen dose because the sedative effects stack. Alcohol amplifies the problem further, which is particularly relevant for the population now receiving high-dose baclofen for alcohol use disorder.

Body weight plays a role in how a given milligram dose translates to tissue concentration, which partly explains why children are so vulnerable. Liver disease, while less directly involved than kidney disease in baclofen clearance, can alter the drug’s distribution and the body’s overall resilience to central nervous system depression. And tolerance matters: someone who has been on baclofen for months at 80 mg per day will generally handle a spike to 120 mg much better than someone who has never taken it before, because the brain adapts to ongoing exposure. That adaptation cuts both ways, though, because it also sets the stage for withdrawal if the drug is stopped suddenly.

1
PubMed. Baclofen overdose: defining the spectrum of toxicity
2
PubMed. Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review
3
PubMed Central. Baclofen overdose: A curious case of medical sales representative
4
Pediatrics. Baclofen Overdose: Drug Experimentation in a Group of Adolescents
5
PubMed. Coma and Respiratory Failure in a 2-Year-Old Child After Accidental Overdose of Baclofen
6
Turkish Journal of Emergency Medicine. Baclofen-induced neurotoxicity in a dialysis patient managed with continuous venovenous hemodialysis: A case report and literature review
7
PubMed Central. Baclofen-induced neurotoxicity in chronic kidney disease: Is there a safe dose?
8
PubMed Central. Baclofen intoxication after accidental ingestion in a 3-year-old child
9
PubMed Central. Oral Baclofen Toxicity in a Pediatric Patient Managed Without Invasive Intervention: A Case Report and Literature Review
10
PubMed. Report of severe accidental baclofen intoxication in a healthy 4-year-old boy and review of the literature
11
PubMed Central. Unusual mechanical failures of intrathecal baclofen pump systems: symptoms, signs, and trouble shooting
12
Nature. Management of acute overdose or withdrawal state in intrathecal baclofen therapy
13
PubMed. Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases
14
PubMed Central. Neurological evolution of severe baclofen intoxication: from brain death mimic to recovered brain function
15
PubMed. Baclofen overdose mimicking brain death
16
PubMed. A Severe Baclofen Intoxication Mimicking Post-Hypoxic Encephalopathy: Wait and See!
17
PubMed Central. Baclofen overdose mimicking anoxic encephalopathy: a case report and review of the literature
18
PubMed. Treating baclofen overdose by hemodialysis
19
PubMed Central. Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review
20
PubMed Central. A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder
21
PubMed. Baclofen and Alcohol-Dependent Patients: A Real Risk of Severe Self-Poisoning